Showing 1 - 1 results of 1 for search 'L. Masanneck', query time: 0.08s
Refine Results
-
1
Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials by J. Ingwersen, L. Masanneck, M. Pawlitzki, S. Samadzadeh, M. Weise, O. Aktas, S. G. Meuth, P. Albrecht
Published 2023-09-01
Article